The Latin America, Middle East and Africa Coronary Artery Bypass Graft Market should witness market growth of 12.5% CAGR during the forecast period (2023-2029).
A speedy recovery is one of the minimally invasive CABGs main benefits. Most patients can go wherever they like and drive immediately after leaving the hospital. In addition, in contrast to the three to four months it takes to recuperate from standard CABG, most people are cleared for all normal physical activities in 10 to 15 days.
Additionally, as the population ages, more seniors receive coronary artery bypass grafting (CABG) recommendations for treating cardiovascular problems. Cardiothoracic surgeons are referred to octogenarians more frequently for surgical revascularization since they have a higher prevalence of coronary artery disease and are the fastest-growing demographic. Favorable reimbursement policies for coronary artery bypass grafting across several nations are anticipated to boost the market's growth.
In the Eastern Cape, where geriatrics make up roughly 10% of the population, less than 12% of the elderly reside there. Furthermore, a significant problem in the majority of Arab Middle Eastern nations is coronary heart disease (CHD). The healthcare industry has grown over the past 10 years to become one of the GCC's most important sectors for promoting economic diversification. All of these variables are anticipated to have a beneficial effect on the growth of the regional market.
The Brazil market dominated the LAMEA Coronary Artery Bypass Graft Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $327.1 million by 2029. The Argentina market is anticipated to grow at a CAGR of 13.1% during (2023-2029). Additionally, The UAE market would display a CAGR of 12.2% during (2023-2029).
Based on Procedure, the market is segmented into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Quadruple CABG Surgery. Based on Method, the market is segmented into Off-pump, On-pump, and Minimally Invasive Direct. Based on End-use, the market is segmented into Hospitals, Cardiology Centers, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Terumo Corporation, Karl Storz SE & Co. KG, Edwards Lifesciences Corporation, Johnson & Johnson (Ethicon, Inc.), Boston Scientific Corporation, Stryker Corporation, LivaNova PLC, Genesee BioMedical, Inc., and Vitalitec International Medizintechnik GmbH (Peters Surgical)
A speedy recovery is one of the minimally invasive CABGs main benefits. Most patients can go wherever they like and drive immediately after leaving the hospital. In addition, in contrast to the three to four months it takes to recuperate from standard CABG, most people are cleared for all normal physical activities in 10 to 15 days.
Additionally, as the population ages, more seniors receive coronary artery bypass grafting (CABG) recommendations for treating cardiovascular problems. Cardiothoracic surgeons are referred to octogenarians more frequently for surgical revascularization since they have a higher prevalence of coronary artery disease and are the fastest-growing demographic. Favorable reimbursement policies for coronary artery bypass grafting across several nations are anticipated to boost the market's growth.
In the Eastern Cape, where geriatrics make up roughly 10% of the population, less than 12% of the elderly reside there. Furthermore, a significant problem in the majority of Arab Middle Eastern nations is coronary heart disease (CHD). The healthcare industry has grown over the past 10 years to become one of the GCC's most important sectors for promoting economic diversification. All of these variables are anticipated to have a beneficial effect on the growth of the regional market.
The Brazil market dominated the LAMEA Coronary Artery Bypass Graft Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $327.1 million by 2029. The Argentina market is anticipated to grow at a CAGR of 13.1% during (2023-2029). Additionally, The UAE market would display a CAGR of 12.2% during (2023-2029).
Based on Procedure, the market is segmented into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Quadruple CABG Surgery. Based on Method, the market is segmented into Off-pump, On-pump, and Minimally Invasive Direct. Based on End-use, the market is segmented into Hospitals, Cardiology Centers, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Terumo Corporation, Karl Storz SE & Co. KG, Edwards Lifesciences Corporation, Johnson & Johnson (Ethicon, Inc.), Boston Scientific Corporation, Stryker Corporation, LivaNova PLC, Genesee BioMedical, Inc., and Vitalitec International Medizintechnik GmbH (Peters Surgical)
Scope of the Study
By Procedure
- Single CABG Surgery
- Double CABG Surgery
- Triple CABG Surgery
- Quadruple CABG Surgery
By Method
- Off-pump
- On-pump
- Minimally Invasive Direct
By End-use
- Hospitals
- Cardiology Centers
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Terumo Corporation
- Karl Storz SE & Co. KG
- Edwards Lifesciences Corporation
- Johnson & Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Stryker Corporation
- LivaNova PLC
- Genesee BioMedical, Inc.
- Vitalitec International Medizintechnik GmbH (Peters Surgical)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. LAMEA Coronary Artery Bypass Graft Market by Procedure
Chapter 5. LAMEA Coronary Artery Bypass Graft Market by Method
Chapter 6. LAMEA Coronary Artery Bypass Graft Market by End-use
Chapter 7. LAMEA Coronary Artery Bypass Graft Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Medtronic PLC
- Terumo Corporation
- Karl Storz SE & Co. KG
- Edwards Lifesciences Corporation
- Johnson & Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Stryker Corporation
- LivaNova PLC
- Genesee BioMedical, Inc.
- Vitalitec International Medizintechnik GmbH (Peters Surgical)
Methodology
LOADING...
